Literature DB >> 6322894

Mammalian platelet adrenoceptors.

R Kerry, M C Scrutton, R B Wallis.   

Abstract

Mammalian platelets vary widely in their responses to catecholamines in part because these agonists can act via excitatory alpha- and inhibitory beta-adrenoceptors. In the absence of antagonists, adrenaline enhances the response of rabbit platelets to an excitatory agonist, e.g. adenosine-5'-O-(1-thiodiphosphate) (ADP-alpha-s) acting at another receptor, but has no effect on the response of rat or guinea pig platelets to such an agonist. In the presence of a beta-adrenoceptor antagonist, adrenaline enhances the response of rat, but not guinea-pig platelets to ADP-alpha-S and the extent of the enhanced effect on rabbit platelets is increased. In the presence of an alpha-adrenoceptor antagonist, adrenaline inhibits the response of rabbit and rat platelets to ADP-alpha-S but has no such effect on the response of guinea-pig platelets. Studies using selective agonists and antagonists demonstrate that the excitatory response of rat platelets to adrenaline is mediated by an alpha 2-adrenoceptor, and the inhibitory response of rabbit platelets to adrenaline by a beta 2-adrenoceptor as is the case in other species which have been examined. The mean alpha 2-adrenoceptor density on human, rabbit, rat and guinea-pig platelets as assessed using [3H]-yohimbine as radioligand is obtained as 258, 270, 42 and less than 10 receptors per platelet. The mean beta 2-adrenoceptor density on human, rabbit, rat and guinea-pig platelets as assessed using (-)-[125I]-iodocyanopindolol is obtained as 66, 14, 41 and less than 5 receptors per platelet. The nature of the effect of adrenaline on the response of mammalian platelets to other excitatory agonists, e.g. ADP-alpha-S, appears therefore to be largely determined by the absolute number of alpha 2-adrenoceptors and by the relative content of alpha 2- and beta 2-adrenoceptors on these cells for the species which have been examined in this analysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322894      PMCID: PMC1986950          DOI: 10.1111/j.1476-5381.1984.tb10748.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding.

Authors:  B B Hoffman; A De Lean; C L Wood; D D Schocken; R J Lefkowitz
Journal:  Life Sci       Date:  1979-05-07       Impact factor: 5.037

2.  Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

Authors:  J A Grant; M C Scrutton
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

3.  Human platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand.

Authors:  M Daiguji; H Y Meltzer; D C U'Prichard
Journal:  Life Sci       Date:  1981-06-15       Impact factor: 5.037

4.  Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.

Authors:  H J Motulsky; S J Shattil; P A Insel
Journal:  Biochem Biophys Res Commun       Date:  1980-12-31       Impact factor: 3.575

5.  A comparative study of platelet aggregation in primates.

Authors:  W F Loeb; B Mackey
Journal:  J Med Primatol       Date:  1973       Impact factor: 0.667

6.  The effects of alpha adrenergic agents on human platelet aggregation.

Authors:  C Y Hsu; D R Knapp; P V Halushka
Journal:  J Pharmacol Exp Ther       Date:  1979-03       Impact factor: 4.030

7.  Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.

Authors:  J A Grant; M C Scrutton
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Potentiation by alpha and inhibition by beta-adrenergic stimulations of rat platelet aggregation. A comparative study with human and rabbit platelets.

Authors:  S K Yu; J G Latour
Journal:  Thromb Haemost       Date:  1977-06-30       Impact factor: 5.249

9.  The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.

Authors:  D C Mills; J B Smith
Journal:  Biochem J       Date:  1971-01       Impact factor: 3.857

10.  Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

View more
  8 in total

1.  Involvement of phosphoinositide metabolism in potentiation by adrenaline of ADP-induced aggregation of rabbit platelets.

Authors:  C Lalau Keraly; J D Vickers; R L Kinlough-Rathbone; J F Mustard
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

2.  An examination of the sources of calcium for contractions mediated by postjunctional alpha 1- and alpha 2-adrenoceptors in several blood vessels isolated from the rabbit.

Authors:  C J Daly; W R Dunn; J C McGrath; D J Miller; V G Wilson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

4.  Inhibition of platelet accumulation by beta 1-adrenoceptor blockade in the thoracic aorta of rabbits subjected to experimental sympathetic activation.

Authors:  K Pettersson; H Björk
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

5.  Extensive and saturable accumulation of paclitaxel by the human platelet.

Authors:  M D Wild; U K Walle; T Walle
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 6.  Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis.

Authors:  Tobias N Bonten; Chiara E I Plaizier; Jaap-Jan D Snoep; Theo Stijnen; Olaf M Dekkers; Johanna G van der Bom
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

7.  Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.

Authors:  J Galitzky; J M Senard; M Lafontan; M Stillings; J L Montastruc; M Berlan
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

8.  Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.

Authors:  C M Brown; A C MacKinnon; J C McGrath; M Spedding; A T Kilpatrick
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.